{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:36Z","timestamp":1774485516140,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44AI094863"],"award-info":[{"award-number":["R44AI094863"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.virol.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T07:48:11Z","timestamp":1505893691000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB\/c mice"],"prefix":"10.1016","volume":"512","author":[{"given":"Brian","family":"Nickols","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Tretyakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Tibbens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Klyushnenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pushko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2017.09.005_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1348-0421.2005.tb03739.x","article-title":"Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice","volume":"49","author":"Bharati","year":"2005","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.virol.2017.09.005_bib2","unstructured":"CDC, 2016. Japanese Encephalitis Vaccine."},{"key":"10.1016\/j.virol.2017.09.005_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcma.2014.12.009","article-title":"Current recommendations for the Japanese encephalitis vaccine","volume":"78","author":"Chen","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.virol.2017.09.005_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4161\/21645515.2014.983412","article-title":"Product review on the JE vaccine IXIARO","volume":"11","author":"Firbas","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.virol.2017.09.005_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib6","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1073\/pnas.1834270100","article-title":"DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus","volume":"100","author":"Hall","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2017.09.005_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.virol.2017.09.005_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.15585\/mmwr.mm6622a3","article-title":"Japanese encephalitis surveillance and immunization - Asia and Western Pacific Regions, 2016","volume":"66","author":"Heffelfinger","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.virol.2017.09.005_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.virol.2016.01.009","article-title":"Next generation sequencing of DNA-launched Chikungunya vaccine virus","volume":"490","author":"Hidajat","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.005_bib10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1099\/jgv.0.000026","article-title":"Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone","volume":"96","author":"Jiang","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2017.09.005_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/338015","article-title":"Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein","volume":"185","author":"Kaur","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.09.005_bib12","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","article-title":"Essential role of cyclization sequences in flavivirus RNA replication","volume":"75","author":"Khromykh","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.005_bib13","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1016\/S0264-410X(03)00382-7","article-title":"Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice","volume":"21","author":"Konishi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib14","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.005_bib15","doi-asserted-by":"crossref","first-page":"19953","DOI":"10.1038\/srep19953","article-title":"Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2017.09.005_bib16","first-page":"165","article-title":"Veterinary vaccines for public health and prevention of viral and bacterial zoonotic diseases","volume":"26","author":"Lutticken","year":"2007","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.virol.2017.09.005_bib17","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2005.08.014","article-title":"Enhancement of immune responses to an HBV DNA vaccine by electroporation","volume":"24","author":"Luxembourg","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vetmic.2017.01.014","article-title":"Japanese encephalitis virus infection, diagnosis and control in domestic animals","volume":"201","author":"Mansfield","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.virol.2017.09.005_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-1702(01)00371-9","article-title":"A 'minimal' approach in design of flavivirus infectious DNA","volume":"81","author":"Mishin","year":"2001","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2017.09.005_bib20","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1016\/j.vaccine.2011.05.071","article-title":"Ensuring the safety of vaccine cell substrates by massively parallel sequencing of the transcriptome","volume":"29","author":"Onions","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.virol.2017.09.005_bib22","series-title":"Novel Technologies for Vaccine Development","first-page":"153","article-title":"Experimental DNA-launched live-attenuated vaccines against infections caused by Flavi-and alphaviruses","author":"Pushko","year":"2014"},{"key":"10.1016\/j.virol.2017.09.005_bib23","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1128\/JVI.75.23.11677-11685.2001","article-title":"Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses","volume":"75","author":"Pushko","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.005_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/14760584.2016.1175943","article-title":"DNA-launched live-attenuated vaccines for biodefense applications","volume":"15","author":"Pushko","year":"2016","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.virol.2017.09.005_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0065-3527(03)61012-2","article-title":"DNA vaccines for flaviviruses","volume":"61","author":"Putnak","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2017.09.005_bib26","first-page":"285","article-title":"Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation","volume":"1","author":"Rice","year":"1989","journal-title":"New Biol."},{"key":"10.1016\/j.virol.2017.09.005_bib27","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12879-016-1873-8","article-title":"Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults","volume":"16","author":"Saito","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virol.2017.09.005_bib28","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1016\/j.vaccine.2016.10.001","article-title":"Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs","volume":"34","author":"Sheng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib29","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1128\/jvi.66.9.5425-5431.1992","article-title":"Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates","volume":"66","author":"Sumiyoshi","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.005_bib30","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/infdis\/jiu114","article-title":"DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice","volume":"209","author":"Tretyakova","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.09.005_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.vaccine.2012.12.050","article-title":"Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine","volume":"31","author":"Tretyakova","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virol.2014.07.050","article-title":"Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice","volume":"468\u2013470","author":"Tretyakova","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.005_bib33","first-page":"7","article-title":"A full-length infectious cDNA clone of zika virus from the 2015 epidemic in Brazil as a genetic platform for studies of virus-host interactions and vaccine development","author":"Tsetsarkin","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.virol.2017.09.005_bib34","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/21645515.2015.1011996","article-title":"Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2015","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.virol.2017.09.005_bib35","unstructured":"WHO, 2015. Japanese encephalitis. Fact sheet No 386."},{"key":"10.1016\/j.virol.2017.09.005_bib36","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/nbt.1593","article-title":"Synthetic viruses: a new opportunity to understand and prevent viral disease","volume":"27","author":"Wimmer","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2017.09.005_bib37","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.micinf.2006.06.010","article-title":"Development of an effective Japanese encephalitis virus-specific DNA vaccine","volume":"8","author":"Wu","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.virol.2017.09.005_bib38","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1128\/JB.00095-10","article-title":"A sequence that affects the copy number and stability of pSW200 and ColE1","volume":"192","author":"Wu","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.virol.2017.09.005_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2015.04.027","article-title":"Development of a human live attenuated West Nile infectious DNA vaccine: conceptual design of the vaccine candidate","volume":"484","author":"Yamshchikov","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.005_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2015.10.015","article-title":"Development of a human live attenuated West Nile infectious DNA vaccine: suitability of attenuating mutations found in SA14-14-2 for WN vaccine design","volume":"487","author":"Yamshchikov","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.005_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/viro.2000.0793","article-title":"A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli","volume":"281","author":"Yamshchikov","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.09.005_bib42","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.09.005_bib43","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1128\/JVI.77.11.6450-6465.2003","article-title":"Development and application of a reverse genetics system for Japanese encephalitis virus","volume":"77","author":"Yun","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.09.005_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3892\/mmr.2015.3419","article-title":"Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB\/c mouse granulocyte-macrophage colony-stimulating factor","volume":"12","author":"Zhai","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217303069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217303069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:13Z","timestamp":1758588133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682217303069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":44,"alternative-id":["S0042682217303069"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2017.09.005","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}